Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa
Abstract Background Dystrophic epidermolysis bullosa (DEB) is a serious, ultra-rare, genetic blistering disease that requires a multidisciplinary care team and lifelong, proactive disease management. To organize and optimize care, we comprehensively examined diagnoses, healthcare use, and annual cos...
Main Authors: | James A. Feinstein, Anna L. Bruckner, Benjamin Chastek, Amy Anderson, Juan Roman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-09-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13023-022-02509-0 |
Similar Items
-
Dystrophic epidermolysis bullosa in a child
by: Uma Eswara
Published: (2012-01-01) -
Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment
by: Kristine A.U. Pallesen, et al.
Published: (2019-09-01) -
Anesthetic consideration in dystrophic epidermolysis bullosa
by: A S Narejo, et al.
Published: (2016-01-01) -
Epidermolysis bullosa pruriginosa
by: Puri Suruchi, et al.
Published: (2005-01-01) -
A case of a patient with severe epidermolysis bullosa surviving to adulthood
by: Hubail AR, et al.
Published: (2018-11-01)